Hi, what are you looking for?
Palantir joins list of 20 most valuable U.S. companies, with stock more than doubling in 2025
FCC greenlights Paramount’s $8 billion merger with entertainment group Skydance
Microsoft’s Satya Nadella says job cuts have been ‘weighing heavily’ on him
Alphabet beats earnings expectations, raises spending forecast
UnitedHealth says it is facing DOJ investigation over Medicare billing practices
Anteros Metals Initiates Channel Sampling at Havens Steady Following Grant Confirmation and Exploration Permit Approval
Questcorp Mining Taps National Inflation Association for Marketing & Investor Outreach Campaign
Crypto Market Update: Americans Still Uninterested in Crypto Despite Institutional Support
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
Allied Critical Metals Launches Allied USA to Expand Tungsten Import and Distribution Operations, Lists on OTCQB, and Receives DTC Eligibility
Chart Mania – 23 ATR Move in QQQ – Metals Lead 2025 – XLV Oversold – XLU Breakout – ITB Moment of Truth
S&P 500 Breaking Out Again: What This Means for Your Portfolio
Momentum Leaders Are Rotating — Here’s How to Find Them
Is META Breaking Out or Breaking Down?
A Wild Ride For the History Books: 2025 Mid-Year Recap
Johnson says Ghislaine Maxwell deserves life sentence over Epstein crimes, rejects potential pardon
Trump hits EU for lack of Gaza aid, says Israel needs to ‘make a decision’ with Hamas not releasing hostages
Trump announces trade deal with European Union
America must win the AI race — and prepare for the worst
Obama issues rare statement on foreign policy issue
Peter Krauth, editor of Silver Stock Investor and Silver Advisor, outlines the factors driving silver’s recent price run, which has pushed the white metal to levels not seen in over a decade.
In his view, the current macroeconomic environment is combining with short supply and strong demand dynamics to create a ‘perfect storm.’
Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.
Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...
Over the past five sessions, the Indian equity markets headed nowhere and continued consolidating in a defined range. In the previous weekly note, it...
A nationwide coordinated crackdown on retail crime — what authorities are calling the first of its kind — led to hundreds of arrests in...
Phase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase 2 and early signs of...